Clinical trials are the final stages of cancer research that assess a potential new drug or therapy that’s already been studied extensively in the laboratory. Trials are carefully monitored scientific studies that involve patients and offer the earliest access to these newest treatment options. Trials are conducted to determine a drug’s proper dose, how well it works and whether it’s more effective than current standard treatments. All drugs, treatment approaches and combinations currently used as standard of care were once studied in clinical trials.
Why it matters
Participating in a clinical trial is the only way to access the very latest options, oftentimes years before they become available to other providers. If you have cancer, you need the very best treatment today, not years from now.
For example, Roswell Park participated in clinical trials of the chemotherapy combination, gemcitabine and capecitabine for biliary cancer, as well as a trial of an FGFR inhibitor for those who have the specific FGFr mutation, two treatment approaches that are now part of the standard of care.
What options are available for biliary cancer?
Through Roswell Park’s expansive research program, we’re able to offer our patients the newest drugs, novel therapeutic approaches and more ways to maximize their survival, including these.
- New therapies using nanoparticle taxanes and oral agent
- Adding a third chemotherapy drug that works in a different way to an established two-drug combination
- A targeted drug for patients whose tumors show changes in NTRK genes
- Agents that target seratonin and neddylation pathways in addition to standard chemotherapy
Available Clinical Trials
Roswell Park opens new clinical trials every day. Learn about currently available clinical trials for gallbladder and bile duct cancers or call 1-800-ROSWELL (1-800-767-9355). Talk to your physician about upcoming trials not yet listed that might be right for you.